Owens Camille V, Najjar Rami S, Bruce Marino A, Beech Bettina M, Montgomery Baxter D
Montgomery Heart & Wellness Center, Houston, TX, USA.
Institute for Biomedical Sciences, Georgia State University, Atlanta, GA, USA.
Am J Lifestyle Med. 2024 Sep 6:15598276241281475. doi: 10.1177/15598276241281475.
Heart failure with reduced ejection fraction (HFrEF) is a major contributor of premature cardiovascular-related deaths. Patients are typically on numerous medications to manage this condition; however, patients continue to experience poor quality of life. Alternative therapeutic approaches are needed to treat HFrEF. The clinical course of seven patients with Stage C and D HFrEF who failed guideline-directed medical therapy were retrospectively analyzed based on medical chart data. All patients consumed a defined, plant-based diet as part of their clinical treatment, and a subset also underwent alternative treatment modalities: External Counterpulsation therapy, BEMER therapy, infrared sauna therapy, ozone therapy, or PlaqueX® therapy. Chart review of these patients indicated improvement in left ventricular ejection fraction (LVEF) and right ventricular systolic pressure (RVSP). All patients also had a significant reduction in medication needs and body weight. Further, all patients reported significant improvements in their quality of life. These data suggest that a defined, plant-based diet combined with other alternative modalities may be efficacious in reducing HFrEF medications and treating Stage C or D HFrEF patients who failed guideline-direct medical therapies. Observations from this case series indicate a need for rigorous prospective studies to confirm these effects.
射血分数降低的心力衰竭(HFrEF)是心血管相关过早死亡的主要原因。患者通常需要服用多种药物来控制这种疾病;然而,患者的生活质量仍然很差。需要其他治疗方法来治疗HFrEF。基于病历数据,对7例C期和D期HFrEF且标准药物治疗无效的患者的临床病程进行了回顾性分析。所有患者均采用特定的植物性饮食作为临床治疗的一部分,部分患者还接受了其他治疗方式:体外反搏治疗、BEMER治疗、红外线桑拿治疗、臭氧治疗或PlaqueX®治疗。对这些患者的病历审查表明,左心室射血分数(LVEF)和右心室收缩压(RVSP)有所改善。所有患者的药物需求和体重也显著降低。此外,所有患者均报告生活质量有显著改善。这些数据表明,特定的植物性饮食与其他替代方式相结合,可能对减少HFrEF药物使用以及治疗标准药物治疗无效的C期或D期HFrEF患者有效。该病例系列的观察结果表明,需要进行严格的前瞻性研究来证实这些效果。